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Induced pluripotent stem cell research has broadened possibilities for regenerative medicine and captured
the world’s attention in a way that science rarely does. However, clinical applications utilizing cultured
stem cells have existed for >30 years and can assist benchers and bedsiders in identifying and expediting
promising avenues for future therapies.The stem cell community generally credits
Till and McCulloch’s transplantation ex-
periments of the 1960s on the hematopoi-
etic system for the demonstration that
adult tissues contain stem cells (Till and
McCulloch, 1961). In those experiments,
so-called colony forming units (CFUs)
were produced by short-term culture of
isolated murine bone marrow cells and
then individually transplanted into irradi-
ated recipients to reconstitute the hema-
topoietic system. From these early in vivo
experiments came the concept that stem
cells are often rare cells that fuel homeo-
stasis and wound repair through their
ability to generate both the proliferating
and the differentiating cells of our tissues.
The notion that stem cells can do so
long term also came from hematopoietic
studies as researchers began to perform
long-term experiments on hematopoietic
stem cells that were isolated and purified
directly from the bonemarrow and serially
transplanted through many generations.
Although the hematopoietic system led
the way in devising concepts for stem cell
biology, the ability to passage stem cells
long term in vitro began in the 1970s
with the pioneering work of Howard
Green on human epithelial stem cells. At
the time, most researchers resorted to
immortalized, transformed cell lines,
which seemed to be the only cells that
could proliferate and differentiate and
yet easily be passaged long term. Cloned
teratocarcinoma cells were particularly
interesting to developmental biologists,
who were examining the ability of these
embryonic-like cells to differentiate along
a variety of lineages in vitro. Green
noticed that epithelial colonies were
among the cell types present within
teratocarcinoma cultures and discovered
that he could clone and propagate them640 Cell Stem Cell 10, June 14, 2012 ª2012on a layer of lethally irradiated, diploid
mouse 3T3 fibroblasts, a line that he
had developed previously. When the
strategy of using a fibroblast feeder layer
was subsequently applied to human
epidermal cells, large colonies of diploid
epithelial keratinocytes grew that retained
their ability to self renew and terminally
differentiate long term (Rheinwald and
Green, 1975).
Green and his colleagues continued to
improve upon the culture conditions
(reviewed by Green, 1991). They added
epidermal growth factor purified from rat
submaxillary glands to the culture condi-
tions, as well as insulin and dexametha-
sone. They also spiked the media with
cholera toxin, a constitutive activator of
cyclic AMP, which also aided cell growth
substantially. As the keratinocyte’s
enormous proliferative powers became
increasingly exposed, so did the promise
to generate sufficiently large sheets of
cultured epidermal cells from a small
piece of healthy skin to cover the
damaged regions of a badly burned
patient. These early studies represent
the birth of what is now a 30 year suc-
cessful application of purified human
stem cells for regenerative medicine
(reviewed by Green, 1991). Therapeutic
uses of cultured stem cells are often
viewed by the public as futuristic, if not
science fiction. We need to work harder
to educate our society of the already ful-
filled wonders of stem cells for medical
applications.
The clinical applications for epithelial
cells have not ended at epidermal cells.
Using very similar culture conditions,
other stratified squamous epithelial stem
cells, including corneal cells, can be
cultured long term in vitro. This ability
led to the subsequent application ofElsevier Inc.cultured corneal progenitors to treat
patients suffering from corneal blindness,
and a 10 year study of successfully
treating 100 such patients was recently
published by Michele De Luca, Grazia
Pellegrini, and colleagues (reviewed by
Rama et al., 2010).
These early culture methods did much
more than ever imagined at the time.
Moreover, they not only paved the way
for these impressive clinical applications,
but in addition they opened the door for
embryonic stem cell (ESC) research as
we know it today. The concept of cocul-
turing epithelial cells with a fibroblast
feeder layer was quickly adapted to
mouse ESCs and worked particularly
well when used in conjunction with con-
ditioned medium from teratocarcinoma
cells (Evans and Kaufman, 1981; Martin,
1981). Once the hurdle of culturing
primary ESCs was overcome, germline
transmission was soon achieved,
providing graphic illustration that ESCs
are truly pluripotent, able to generate the
210 cell types of the mouse (Robertson
et al., 1986).
Although the early mammalian cell
culture studies were instrumental in
bringing stem cells to a clinical setting,
a two decade gap separated those
advances from the ones of Yamanaka
and colleagues that have captivated the
interests of scientists and public alike
(Takahashi and Yamanaka, 2006). What
accounted for this gap and how can we
expedite progress in regenerative medi-
cine in the years to come? Below are a
few ideas based upon the history of the
field and my own experiences as a stem
cell biologist.
As a postdoctoral fellow and
biochemist in Green’s laboratory in the
late 1970s, I was far more fascinated by
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balance growth and differentiation at a
molecular level than I was in the scientifi-
cally more mundane, albeit more immedi-
ately relevant, task of optimizing culture
conditions for burn therapy. Although
placing stem cells into a molecular frame-
work has taken three additional decades
to evolve, there are several recent indica-
tions that continuing to build upon this
foundation will be the engine that drives
regenerative medicine in the future. In
this regard, it is intriguing that cyclic
AMP, one of the culture additives that
advancedepithelial regenerativemedicine
in the 1970s, was recently found to act
downstream in the Wnt signaling pathway
(Goessling et al., 2011), known to have
a powerful impact on stemcells and tissue
regeneration. This new knowledge has
now been translated into an FDA-
approved phase 1 clinical trial that could
significantly improve human cord blood
transplantations (Goessling et al., 2011).
On a similar note, in converting skin fibro-
blasts to iPSCs,Yamanakaandcoworkers
achieved their success by exploiting not
only mammalian cell culture technology
but alsoknowledgeof themolecular differ-
ences between human ESCs and fibro-
blasts. By employing an amazingly simple
screen to weed out nonessential genes in
these differential patterns of gene expres-
sion, the researchers honed in on the key
transcription factors that promote an
embryonic-like fate (Takahashi andYama-
naka, 2006). This knowledge, based
squarely upon the molecular foundations
of ESC biology, is now fueling efforts to
identify small molecules that will optimize
iPSC derivation and culture. In other
words, while the field began with cell
culture to fuel molecular insights into
stem cell biology (as discussed in, for
example, Blanpain and Fuchs, 2009), the
molecular insights are now fueling ap-
proaches to expand the repertoire and
populations of cultured stem cells that
can be applied in the clinics.
Another relevant lesson stemming from
the dawn of epidermal stem cell biology is
that keratinocytes alter their program of
gene expression in culture. Based upon
what we currently understand about the
extraordinary complexities of skin stem
cell niches (reviewed in Blanpain and
Fuchs, 2009), it seems unlikely that this
will be fully rectified no matter what we
may do to optimize culture conditions.That said, the long-standing success of
cultured human keratinocytes for burn
therapy and the absence of skin cancers
in patients engrafted decades ago
suggests that epidermal progenitors do
not lose their stemness when passaged
in vitro, nor do they become transformed.
Analogously, when engrafted onto the
backs of hairless mice, murine hair follicle
stem cells passaged in vitro can generate
epidermis, sebaceous glands, and hair
follicles, and they even seem to be
able to collaborate with dermal cells in
recreating a new stem cell niche (re-
viewed in Blanpain and Fuchs, 2009).
These findings suggest that as long as
their capacity for long-term self-renewal
and differentiation can be faithfully main-
tained in vitro, cultured stem cells should
continue to hold promise for regenerative
medicine even if they transiently adopt
a new molecular program when pro-
pagated outside their normal microenvi-
ronment. As exciting as this concept is,
with few exceptions, stem cell popula-
tions are in limited supply, posing sig-
nificant hurdles even for stem cells such
as corneal or hematopoietic stem cells
where clinical applications are well estab-
lished. Taking a page from developmental
biology, it would seem that one good way
to overcome these barriers would be to
funnel our collective research energies
into enhancing our knowledge of stem
cell activation and self-renewal.
Such strategies are ones that are
already being actively pursued by a
number of stem cell researchers. Indeed,
the aim to enhance hematopoietic stem
cell self-renewal in vitro was behind the
Zon group’s efforts to conduct their
cleverly devised zebrafish screen for
FDA-approved small molecules that could
enhance the process in vivo. This in turn
resulted in the identification of dimethyl-
prostaglandin E2 (dmPGE2), which has
not only provided a possible link between
cAMP and Wnt stem cell signaling path-
waysbuthasalso led to thephase1clinical
trials described above (Goessling et al.,
2011). And in a recent RNAi screen for
self-renewing hair follicle stem cell genes,
clues have surfaced that might be ex-
ploited to improve epithelial stem cell
expansion in vitro (Chen et al., 2012). If
so, this could aid current treatments for
corneal blindness, where stem cell num-
bers are often the rate-limiting step to
success (reviewed by Rama et al., 2010).Cell Stem CellAn alternative route to overcoming the
limited supplies of cultured stem cells is
to transdifferentiate closely related cells
that are either in greater supply or which
can be propagated more easily in vitro
than the desired stem cell. For instance,
if we can gain an understanding of
the transcriptional differences between
corneal and skin stem cells, can we
exploit this information to transdifferenti-
ate skin stem cells into corneal stem
cells? Given the close relation between
these two types of stratified squamous
epithelial progenitors, such an approach
seems like a baby step relative to Yama-
naka’s giant step that launched the
game of transdifferentiation hopscotch.
Although the borders between dreaming
and thinking beyond the box can some-
times be quite blurred, the recent
successes of Wernig and others (re-
viewed by Chambers and Studer, 2011)
suggest that this may be the most acces-
sible route to future clinical applications.
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